Session Information
2013 Summer Meeting
Click here to go to the previous page
New Hypertension and Cholesterol Guidelines: Stay Tuned
Track:
Education Sessions (CE)
Program Code: 127-L01
Date: Tuesday, June 4, 2013
Time: 9:00 AM to 11:00 AM EST
Location:
101 H, Level 1
PRESENTER:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Description
The National Heart Lung and Blood Institute (NHLBI) is working on the new hypertension and dyslipidemia guidelines, the JNC 8 and ATP 4. With new consensus-based guidelines and recommendations will come new challenges. This session will review the overall recommendations expected from these new guidelines, and will focus on ways that pharmacists can implement these recommendations.
- Analyze the key components and the proven clinical benefits of hypertension and dyslipidemia pharmacist-managed clinical services.
- Apply the new guideline and consensus document recommendations to the clinical care of patients with hypertension and dyslipidemia.
- Describe clinical controversies related to the optimal use of antihypertensive and dyslipidemia pharmacotherapy.
- Identify changes that you can make in your practice that will help to achieve the overall intent of the new evidence-based recommendations.
| No items are available for this session. |